Should we redefine hypertension?

Current Cardiology Reports

Volumn 8, Issue 6, 2006, Pages 395-398

  Giles, Thomas D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INDAPAMIDE; PERINDOPRIL; PLACEBO; RAMIPRIL;

ARTERIAL PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE COURSE; HEALTH EDUCATION; HEALTH PROGRAM; HEART INFARCTION; HUMAN; HYPERTENSION; PHYSICIAN; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DIFFERENTIAL THRESHOLD; HUMANS; HYPERTENSION; RISK FACTORS; TERMINOLOGY;

EID: 33750988763     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0095-x     Document Type: Review

References (16)

1. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
2. Klag MJ, Whelton PK, Randall BL, et al.: Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
3. Vasan RS, Larson MG, Leip EP, et al.: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
4. Lewington S, Clarke R, Qizilbash N, et al., for the Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
5. Fesler P, du Cailar G, Ribstein J, Mimran A: Heterogeneity of cardiorenal characteristics in normotensive subjects. Hypertension 2004, 43:219-223.
6. Sarnak MJ, Greene T, Wang X, et al.: The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease study. Ann Intern Med 2005, 142:342-351.
7. Jackson R, Lawes CM, Bennett DA, et at.: Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005, 365:434-441.
8. Chobanian A, Bakris G, Black H, et al., and the National High Blood Pressure Education Program Coordinating Committee: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2571.
9. Wang Y, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004, 164:2126-2134.
10. Cohn JN: Arteries, myocardium, blood pressure and cardiovascular risk: towards a revised definition of hypertension. J Hypertens 1998, 16(Pt 2):2117-2124.
11. Neaton JD, Went-worth D: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992, 152:56-64.
12. Giles TD, Berk BC, Black HR, et al., on behalf of the Hypertension Writing Group: Expanding the definition and classification of hypertension. J Clin Hypertens 2005, 7:505-512.
13. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145-153.
14. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041.
15. Nissen SE, Tuzcu EM, Libby P, et al., for the CAMELOT Investigators: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trial. JAMA 2004, 292:2217-2225.
16. Julius S, Nesbitt SD, Eagan BM, et al., for the Trial of Preventing Hypertension (TROPHY) Study Investigators: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006, 354:1-13.